Search research articles
Contact Us
Filters
Showing results (321-330 of 393) with videos related to
Page
of 40
Sort By:
Cancer
|
June 19, 2014
Oncolytic polio virotherapy of cancer
Michael C Brown, Elena Y Dobrikova, Mikhail I Dobrikov, et al.
Radiation Research
|
August 4, 2024
Effect of Age at Time of Irradiation, Sex, Genetic Diversity, and Granulopoietic Cytokine Radiomitigation on Lifespan and Lymphoma Development in Murine H-ARS Survivors
P Artur Plett, Hui Lin Chua, Tong Wu, et al.
Cancer
|
January 24, 2020
Current multidisciplinary management of brain metastases
Michael J Moravan, Peter E Fecci, Carey K Anders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells
Ling-Yuan Kong, Mohamed K Abou-Ghazal, Jun Wei, et al.
Neuro-Oncology
|
November 7, 2017
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro, Gordana Vlahovic, Michael Lim, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial
Alvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.
Annals of Internal Medicine
|
August 1, 1994
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group
M N Dohn, W G Weinberg, R A Torres, et al.
Plos One
|
April 12, 2014
EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma
Hongsheng Miao, Bryan D Choi, Carter M Suryadevara, et al.
Neuro-Oncology
|
March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
Jennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 6, 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma
David A Reardon, Scott Turner, Katherine B Peters, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 393) with videos related to
Sort By:
Page
of 40
Cancer
|
June 19, 2014
Oncolytic polio virotherapy of cancer
Michael C Brown, Elena Y Dobrikova, Mikhail I Dobrikov, et al.
Radiation Research
|
August 4, 2024
Effect of Age at Time of Irradiation, Sex, Genetic Diversity, and Granulopoietic Cytokine Radiomitigation on Lifespan and Lymphoma Development in Murine H-ARS Survivors
P Artur Plett, Hui Lin Chua, Tong Wu, et al.
Cancer
|
January 24, 2020
Current multidisciplinary management of brain metastases
Michael J Moravan, Peter E Fecci, Carey K Anders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells
Ling-Yuan Kong, Mohamed K Abou-Ghazal, Jun Wei, et al.
Neuro-Oncology
|
November 7, 2017
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro, Gordana Vlahovic, Michael Lim, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial
Alvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.
Annals of Internal Medicine
|
August 1, 1994
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group
M N Dohn, W G Weinberg, R A Torres, et al.
Plos One
|
April 12, 2014
EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma
Hongsheng Miao, Bryan D Choi, Carter M Suryadevara, et al.
Neuro-Oncology
|
March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
Jennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 6, 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma
David A Reardon, Scott Turner, Katherine B Peters, et al.
Page
of 40